Literature DB >> 14662943

Borna disease virus RNA in immunocompromised patients in southwestern France.

Emmanuelle Cotto1, Didier Neau, Martine Cransac-Neau, Marc Auriacombe, Jean-Luc Pellegrin, Jean-Marie Ragnaud, Anne-Marie Fillet, Magali Belnard, Hervé Fleury, Marie-Edith Lafon.   

Abstract

Borna disease virus (BDV) is a neurotropic RNA virus with a wide host range. Human infections, although controversial, have been described in Europe, Asia, and the United States. The present study investigated the existence of BDV infections in immunocompromised human beings, namely, 82 human immunodeficiency virus (HIV)-infected and 80 therapeutically immunosuppressed patients. BDV p40 RNAs were detected in peripheral white blood cells with reverse transcription-nested PCR and hybridization in, respectively, 11 (13.41%) and 1 (1.25%) of the two groups of patients. BDV p24 RNAs were identified in only one of those. BDV RNA was detected in the absence of any neuropsychiatrical illness, suggesting that BDV infections may occur in asymptomatic carriers. The severity and particularity of cellular immunosuppression could explain the significantly increased detection of BDV RNA in HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662943      PMCID: PMC308971          DOI: 10.1128/JCM.41.12.5577-5581.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  42 in total

1.  Construction of an internal standard used in RT nested PCR for Borna Disease Virus RNA detection in biological samples.

Authors:  V Legay; C Sailleau; G Dauphin; S Zientara
Journal:  Vet Res       Date:  2000 Nov-Dec       Impact factor: 3.683

2.  Borna disease virus antibodies in French horses.

Authors:  J Galabru; M F Saron; M Berg; A L Berg; S Herzog; J Labie; S Zientara
Journal:  Vet Rec       Date:  2000-12-16       Impact factor: 2.695

Review 3.  Epidemiology of Borna disease virus.

Authors:  Peter Staeheli; Christian Sauder; Jürgen Hausmann; Felix Ehrensperger; Martin Schwemmle
Journal:  J Gen Virol       Date:  2000-09       Impact factor: 3.891

4.  Low avidity of human serum antibodies for Borna disease virus antigens questions their diagnostic value.

Authors:  U Allmang; M Hofer; S Herzog; K Bechter; P Staeheli
Journal:  Mol Psychiatry       Date:  2001-05       Impact factor: 15.992

Review 5.  Borna disease virus and human disease.

Authors:  K M Carbone
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

Review 6.  Borna disease virus and psychiatry.

Authors:  O Taieb; J M Baleyte; P Mazet; A M Fillet
Journal:  Eur Psychiatry       Date:  2001-02       Impact factor: 5.361

Review 7.  Borna disease virus--does it infect humans and cause psychiatric disorders?

Authors:  K Lieb; P Staeheli
Journal:  J Clin Virol       Date:  2001-05       Impact factor: 3.168

8.  Experimental and natural borna disease virus infections: presence of viral RNA in cells of the peripheral blood.

Authors:  T W Vahlenkamp; H K Enbergs; H Müller
Journal:  Vet Microbiol       Date:  2000-10-01       Impact factor: 3.293

Review 9.  Borna disease virus: a mystery as an emerging zoonotic pathogen.

Authors:  J A Richt; R Rott
Journal:  Vet J       Date:  2001-01       Impact factor: 2.688

Review 10.  Borna disease virus.

Authors:  I Jordan; W I Lipkin
Journal:  Rev Med Virol       Date:  2001 Jan-Feb       Impact factor: 6.989

View more
  3 in total

Review 1.  Early qualitative risk assessment of the emerging zoonotic potential of animal diseases.

Authors:  Stephen Palmer; David Brown; Dilys Morgan
Journal:  BMJ       Date:  2005-11-26

2.  Borna disease virus (BDV) circulating immunocomplex positivity in addicted patients in the Czech Republic: a prospective cohort analysis.

Authors:  Sylva Rackova; Lubos Janu; Hana Kabickova
Journal:  BMC Psychiatry       Date:  2010-09-08       Impact factor: 3.630

Review 3.  Infectious diseases of the central nervous system.

Authors:  Danièlle Gunn-Moore
Journal:  Vet Clin North Am Small Anim Pract       Date:  2005-01       Impact factor: 2.093

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.